Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor alpha1 (TRalpha1) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRalpha1 and TRbeta1 by 77% and 25%, respectively. Debutyldronedarone hydrochloride can be used for the research of arrhythmic[1].
Molecular Weight:
537.11
Purity:
98.73
CAS Number:
[197431-02-0]
Formula:
C27H37ClN2O5S
Target:
Thyroid Hormone Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted